Michael Kope
Gründer bei Cyclarity Therapeutics, Inc.
Profil
Michael Kope founded Cyclarity Therapeutics, Inc., where he worked as Chief Executive Officer-Corporate Affairs.
Mr. Kope also formerly worked at Aridis Pharmaceuticals, Inc., as Vice President & Corporate Development Consultant.
Mr. Kope received his graduate degree in 1990 from the University of Michigan.
Aktive Positionen von Michael Kope
Unternehmen | Position | Beginn |
---|---|---|
Cyclarity Therapeutics, Inc.
Cyclarity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyclarity Therapeutics, Inc. provides technology to treat, cure, and reverse atherosclerosis. It develops simple and direct interventions targeting toxic forms of cholesterol using rationally designed molecules to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. The company was founded by Michael Kope and Matthew O?Connor and is headquartered in Mountain View, CA. | Gründer | - |
Ehemalige bekannte Positionen von Michael Kope
Unternehmen | Position | Ende |
---|---|---|
ARIDIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Michael Kope
University of Michigan | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ARIDIS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Cyclarity Therapeutics, Inc.
Cyclarity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyclarity Therapeutics, Inc. provides technology to treat, cure, and reverse atherosclerosis. It develops simple and direct interventions targeting toxic forms of cholesterol using rationally designed molecules to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. The company was founded by Michael Kope and Matthew O?Connor and is headquartered in Mountain View, CA. | Commercial Services |